Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone

Anker, 1997, Hormonal changes and catabolic/anabolic imbalance in chronic heart failure, Circulation, 96, 526, 10.1161/01.CIR.96.2.526 Underwood, 1992, Normal and aberrant growth, 1079 Bentham, 1993, Acquired growth hormone resistance in patients with hypercatabolism, Horm Res, 40, 87, 10.1159/000183772 Ross, 1995, Acquired growth hormone resistance, Eur J Endocrinol, 132, 655, 10.1530/eje.0.1320655 Fazio, 1996, A preliminary study of growth hormone in the treatment of dilated cardiomyopathy, N Engl J Med, 334, 809, 10.1056/NEJM199603283341301 Genth-Zotz, 1999, Recombinant growth hormone therapy in patients with ischemic cardiomyopathy, Circulation, 99, 18, 10.1161/01.CIR.99.1.18 Frustaci, 1996, Growth hormone in the treatment of dilated cardiomyopathy, N Engl J Med, 335, 672, 10.1056/NEJM199608293350915 Osterziel, 1998, Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy, Lancet, 351, 1233, 10.1016/S0140-6736(97)11329-0 Isgaard, 1998, A placebo controlled study of growth hormone in patients with congestive heart failure, Eur Heart J, 19, 1704, 10.1053/euhj.1998.1123 Goddard, 1995, Mutations of the growth hormone receptor in children with idopathic short stature, N Engl J Med, 333, 1093, 10.1056/NEJM199510263331701 Sotiropoulos, 1993, Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor, Endocrinology, 132, 1863, 10.1210/endo.132.4.8462483 Anker, 1997, The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure, Eur Heart J, 18, 259, 10.1093/oxfordjournals.eurheartj.a015229 Anker, 1999, Cardiac cachexia, Chest, 115, 836, 10.1378/chest.115.3.836 Strasburger, 1996, Immunofunctional assay of human growth hormone (hGH) in serum, J Clin Endocrinol Metab, 81, 2613 Strasburger, 1994, Non-isotopic two-site immunoassay for IGFBP-3, Growth Regul, 4, 138 Pflaum, 1993, A nonisotopic solid phase immunoassay for the determination of human growth hormone binding protein, Exp Clin Endocrinol, 101, 44 Anker, 1999, Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure, Eur Heart J, 20, 683, 10.1053/euhj.1998.1446 Volterrani, 1997, Hemodynamic effects of intravenous growth hormone in congestive heart failure, Lancet, 349, 1067, 10.1016/S0140-6736(97)24015-8 Giustina, 1999, Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure, Am Heart J, 137, 1035, 10.1016/S0002-8703(99)70359-5 Blum, 1997, Radioimmunoassays for IGFs and IGFBPs, Growth Regul, 7, 11 Blum, 1996, Insulin-like growth factors and their binding proteins, 190 Swan, 1997, Insulin resistance in chronic heart failure, J Am Coll Cardiol, 30, 527, 10.1016/S0735-1097(97)00185-X Anker, 1997, Wasting as independent risk factor of survival in chronic heart failure, Lancet, 349, 1050, 10.1016/S0140-6736(96)07015-8 Assy, 1998, Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis, Dig Dis Sci, 43, 1317, 10.1023/A:1018828412631 Fisker, 1997, Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults, J Clin Endocrinol Metab, 82, 123 Bengtsson, 1997, Cardiovascular effects of GH, Endocrinology, 152, 1, 10.1677/joe.0.1520001 Ross, 1999, Growth hormone, cardiomyocyte contractile reserve, and heart failure, Circulation, 99, 15, 10.1161/01.CIR.99.1.15 Spallarossa, 1999, Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease, Am J Cardiol, 84, 430, 10.1016/S0002-9149(99)00328-8 Osterziel, 2000, The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration, Clin Endocrinol Metab, 85, 1533 Moxley, 1994, Potential for growth factor treatment of muscle disease, Curr Opin Neurol, 7, 427, 10.1097/00019052-199410000-00011 Takala, 1999, Increased mortality associated with growth hormone treatment in critically ill adults, N Engl J Med, 341, 785, 10.1056/NEJM199909093411102 Demling, 1999, Growth hormone therapy in critically ill patients, N Engl J Med, 341, 837, 10.1056/NEJM199909093411110 Windisch, 1998, Recombinant human growth hormone for AIDS-associated wasting, Ann Pharmacother, 32, 437, 10.1345/aph.17255 Van Loon, 1998, Safety of high doses of recombinant human growth hormone, Horm Res, 49, 78, 10.1159/000053092 Cuneo, 1989, Cardiac failure responding to growth hormone, Lancet, 333, 838, 10.1016/S0140-6736(89)92290-3 O’Driscoll, 1997, Treatment of end-stage cardiac failure with growth hormone, Lancet, 349, 1068, 10.1016/S0140-6736(05)62290-8 O’Sullivan, 1989, Insulin-like growth factor 1 (IGF-1) in mice reduces weight loss during starvation, Endocinology, 125, 2793, 10.1210/endo-125-5-2793 Guler, 1987, Short-term metabolic effects of recombinant human insulin-like growth factor in healthy adults, N Engl J Med, 317, 137, 10.1056/NEJM198707163170303 Hankinson, 1998, Circulating concentrations of insulin-like growth factor-I and risk of breast cancer, Lancet, 351, 1393, 10.1016/S0140-6736(97)10384-1 Chan, 1998, Plasma insulin-like growth factor-I and prostate cancer risk, Science, 279, 563, 10.1126/science.279.5350.563 Qureshi, 1998, Factors predicting malnutrition in hemodialysis patients, Kidney Int, 53, 773, 10.1046/j.1523-1755.1998.00812.x Moller, 1996, Prognostic value of insulin-like growth factor I and its binding protein in patients with alcohol-induced liver disease, Hepatology, 23, 1073, 10.1002/hep.510230521 Freeman, 1998, Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure, Vet Intern Med, 12, 440, 10.1111/j.1939-1676.1998.tb02148.x Jenkins, 1996, Growth hormone therapy for protein catabolism, Q J Med, 89, 813, 10.1093/qjmed/89.11.813